| # | Drug | Count |
|---|---|---|
| 0 | LEUPROLIDE ACETATE | 645 |
| 1 | DENOSUMAB | 630 |
| 2 | DARBEPOETIN ALFA | 320 |
| 3 | CLOZAPINE | 292 |
| 4 | ADALIMUMAB | 273 |
| 5 | OCTREOTIDE ACETATE | 231 |
| 6 | ETANERCEPT | 221 |
| 7 | METHOTREXATE SODIUM | 191 |
| 8 | INFLIXIMAB | 190 |
| 9 | TOCILIZUMAB | 186 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AFLIBERCEPT-JBVF | 1 | 0.0625 |
| 1 | TRIPTORELIN PAMOATE | 74 | 0.0285 |
| 2 | GOLD | 135 | 0.0232 |
| 3 | CANAKINUMAB | 152 | 0.0139 |
| 4 | MINOCYCLINE HYDROCHLORIDE | 82 | 0.0138 |
| 5 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 2 | 0.0133 |
| 6 | ANAKINRA | 154 | 0.0091 |
| 7 | LEUPROLIDE ACETATE | 645 | 0.0083 |
| 8 | OCTREOTIDE ACETATE | 231 | 0.0075 |
| 9 | NITROFURANTOIN (MACROCRYSTALS) | 4 | 0.0065 |
| # | Drug class | Count |
|---|---|---|
| 0 | RANK Ligand Inhibitor [EPC] | 630 |
| 1 | Atypical Antipsychotic [EPC] | 353 |
| 2 | Erythropoiesis-stimulating Agent [EPC] | 320 |
| 3 | Opioid Agonist [EPC] | 309 |
| 4 | Corticosteroid [EPC] | 305 |
| 5 | Endothelin Receptor Antagonist [EPC] | 280 |
| 6 | Kinase Inhibitor [EPC] | 261 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 256 |
| 8 | Tumor Necrosis Factor Blocker [EPC] | 251 |
| 9 | Benzodiazepine [EPC] | 229 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 20 | 0.0291 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 154 | 0.0091 |
| 2 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 3 | Erythropoiesis-stimulating Agent [EPC] | 320 | 0.0059 |
| 4 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 7 | 0.0056 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 21 | 0.0042 |
| 6 | Provitamin D2 Compound [EPC] | 112 | 0.0038 |
| 7 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 8 | Cholinesterase Inhibitor [EPC] | 62 | 0.0032 |
| 9 | RANK Ligand Inhibitor [EPC] | 630 | 0.0031 |